Evidence map›Paper›PMID 29182564›Full record

ArticleInternational journal of environmental research and public health2017

Oral Mucositis in Pediatric Patients in Treatment for Acute Lymphoblastic Leukemia.

Isabella Lima Arrais Ribeiro, Rebecca Rhuanny Tolentino Limeira, Ricardo Dias de Castro, Paulo Rogério Ferreti Bonan, Ana Maria Gondim Valença

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06560879 (Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06560879 phase2enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorNational Institute of Pediatrics, MexicoRan2025 to 2026Enrolled120ConditionsProbiotics, Gastrointestinal Diseases, Precursor Cell Lymphoblastic Leukemia-LymphomaArmsLactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Placebo
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Healing Oral Mucositis WithBioMed research international · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Photobiomodulation for the prevention and treatment of oral mucositis in patients submitted to hematopoietic stem cell transplantation: health quality evaluation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  11. Article
  12. Article
  13. The Implementation of an Integrated Oral Care Protocol for Pediatric Cancer Patients: a Qualitative Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023
    Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Medicinal Plants with Anti-Leukemic Effects: A Review.Molecules (Basel, Switzerland) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Isabella Lima Arrais RibeiroPost-Doctorate Researcher in Post-Graduate Program in Dentistry, Universidade Federal da Paraíba, João Pessoa, Paraíba 5045, Brazil. isabella_arrais@yahoo.com.ORCID 0000-0001-6538-6811
Rebecca Rhuanny Tolentino LimeiraMaster student in Post-Graduate Program in Dentistry, Universidade Federal da Paraíba, João Pessoa, Paraíba 5045, Brazil. rebecca.rhuanny@yahoo.com.br.
Ricardo Dias de CastroDepartment of Clinical and Social Dentistry, Universidade Federal da Paraíba, João Pessoa, Paraíba 5045, Brazil. ricardodiasdecastro@yahoo.com.br.
Paulo Rogério Ferreti BonanDepartment of Clinical and Social Dentistry, Universidade Federal da Paraíba, João Pessoa, Paraíba 5045, Brazil. pbonan@yahoo.com.ORCID 0000-0002-4449-4343
Ana Maria Gondim ValençaDepartment of Clinical and Social Dentistry, Universidade Federal da Paraíba, João Pessoa, Paraíba 5045, Brazil. anamvalenca@gmail.com.
Universidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral mucositis in oncologic patients is the most undesirable event of the chemotherapeutic treatment. This study aimed to identify damage to the oral cavity resulting from chemotherapy in pediatric patients with acute lymphoblastic leukemia (ALL). This is a prospective study with a sample of 42 children and adolescents evaluated for 10 consecutive weeks after diagnosis. The modified Oral Assessment Guide (OAG) was used, and data were analyzed by Spearman's rank correlation coefficient (α = 5%). Changes to the normal lips and saliva were positively related to an increase in the OAG score during all 10 weeks of evaluation. Alterations to the labial mucosa were correlated with an increase in the OAG score from the 2nd to 10th week, which was also found for changes in the tongue and in the swallowing function in Weeks 1, 6, 8, 9, and 10 and for gum changes from the 5th to 7th week. No significant vocal changes were correlated with the total OAG score at any point during the monitoring period. Changes in lips, cheek and/or palatal mucosa, labial mucosa, and gum areas and in swallowing function were positively correlated with an increase in the severity of oral mucositis in patients with ALL after beginning chemotherapeutic treatment.

Indexed as

AdolescentAntineoplastic AgentsChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMouth MucosaPrecursor Cell Lymphoblastic Leukemia-LymphomaProspective StudiesStomatitisAntineoplastic Agentsadolescentchildlymphoid leukemia

Identifiers

PMID29182564
PMCPMC5750887
OpenAlexW2770561270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.